首页 | 官方网站   微博 | 高级检索  
     

宫颈癌组织AKT和P-AKT表达与LMVD相关性及其对新辅助化疗效果预测意义
引用本文:许振,刘志强,郭庆枝,孙莉.宫颈癌组织AKT和P-AKT表达与LMVD相关性及其对新辅助化疗效果预测意义[J].中华肿瘤防治杂志,2017(13):906-911.
作者姓名:许振  刘志强  郭庆枝  孙莉
作者单位:滨州医学院附属医院妇科,山东 滨州,256600
摘    要:目的 宫颈癌新辅助化疗(neoadjuvant chemotherapy,NACT)的疗效一直存在争议,PI3K/AKT通路在肿瘤细胞增殖、迁移、侵袭及抗凋亡都起到举足轻重的作用.本研究探讨NACT对宫颈鳞状细胞癌AKT通路中AKT及P-AKT的表达对肿瘤微淋巴管生成的影响,并分析其变化与NACT临床疗效的关系.方法 采用免疫组化SP法分别检测2011-03-01-2016-03-31滨州医学院附属医院收治的47例 ⅠB2~ⅡB期宫颈鳞癌患者行NACT前后AKT和P-AKT的表达情况及肿瘤微淋巴管密度(lymphatic microvessel density,LMvD)的变化.结果 免疫组化检测结果显示,NACT前AK和P-AKT的阳性率分别为93.6%和72.3%,化疗后阳性率分别为44.7%和36.2%,NACT前后比较,AKT和P-AKT表达差异有统计学意义,P<0.001.化疗前宫颈鳞癌组织中LMvD计数为20.87±3.31,化疗后宫颈鳞癌组织中LMvD计数为16.47±3.44,化疗后宫颈鳞癌组织中LMvD明显降低,t=6.32,P<0.001.化疗前宫颈鳞癌AKT阳性的LMvD为21.14±3.19,高于阴性组(17.00±3.00).Spearman相关分析显示,化疗前后LMvD的表达(rs=0.39,P=0.007)与化疗前后P-AKT的表达(rs=0.66,P<0.001)均呈正相关.化疗后LMvD与化疗后AKT的表达呈正相关,rs=0.58,P<0.001.淋巴结转移与化疗前后LMvD均呈正相关(rs=0.44,P<0.001;rs=0.36,P=0.013).淋巴结转移的患者化疗前化疗后LMvD均高于淋巴结未转移者.结论 化疗前P-AKT的表达及化疗后AKT和P-AKT的表达与肿瘤微淋巴管生成呈正相关,LMvD与淋巴结的转移呈正相关,化疗前P-AKT的表达有可能作为预测宫颈癌新辅助化疗疗效的指标.

关 键 词:宫颈癌  新辅助化疗  AKT  P-AKT  微淋巴管密度

Expression of AKT,P-AKT in cervical cancer before and after neoadjuvant chemotherapy and its effect on lymphangiogenesis and clinical significance
XU Zhen,LIU Zhi-qiang,GUO Qing-zhi,SUN Li.Expression of AKT,P-AKT in cervical cancer before and after neoadjuvant chemotherapy and its effect on lymphangiogenesis and clinical significance[J].Chinese Journal of Cancer Prevention and Treatment,2017(13):906-911.
Authors:XU Zhen  LIU Zhi-qiang  GUO Qing-zhi  SUN Li
Abstract:OBJECTIVE The therapeutic effect of neoadjuvant chemotherapy (NACT)in cervical cancer has been controversial.The PI3K/AKT pathway plays an important role in tumor cell proliferation,migration and invasion and an-ti-apoptosis.The aims of this article was to examine the effect of AKT and P-AKT on lymphangiogenesis in cervical squa-mous carcinoma with neoadjuvant chemotherapy and analyze the association of their expression with the clinical efficacy. METHODS The expression of AKT,P-AKT and density of lymphatic microvessels (LMvD)in 47 cervical squamous cell carcinomas treated with neoadjuvant chemotherapy from March 1,2011 to March 31,2016 in Binzhou Medical College,Af-filiated Hospital were detected by immunohistochemistry method.RESULTS The expression of AKT and P-AKT before chemotherapy was detected in 93.6% and 72.3% of all cases,while the expression of AKT and P-AKT after chemothera-py was observed in 44.7% and 36.2%.The expression of AKT in tumors after neoadjuvant chemotherapy was different with that in tuomrs before and after neoadjuvant chemotherapy (P <0.001).LMvD count was 20.87±3.31 in cervical squamous cell carcinoma before chemotherapy and 16.47±3.44 after chemotherapy.The level of LMvD after chemother-apy was decreased (t=6.32,P <0.001).The positive rate of AKT positive in cervical squamous cell carcinoma was 21.14 ±3.19,which was higher than that in negative group (17.00±3.00).Spearman correlation analysis showed that LMvD was positively correlated with P-AKT expression before and after chemotherapy (rs = 0.39;P = 0.007,rs = 0.66,P <0.001).LMvD was positively correlated with AKT expression after chemotherapy (rs =0.58,P <0.001).There was a positive correlation between lymph node metastasis and LMvD before and after chemotherapy (rs =0.44,P <0.001;rs =0.36,P =0.013).Whether before chemotherapy or after chemotherapy,LMDv in lymph node-positive patients was higher than that in lymph node-negative patients.CONCLUSIONS The expression of P-AKT before neoadjuvant chemo-therapy and the expression of AKT and P-AKT after neoadjuvant chemotherapy are positively correlated with the lym-phangiogenesis,and LMvD is positively correlated with the lymph node metastasis.Before chemotherapy,P-AKT expres-sion may be served as a potential predictor of neoadjuvant chemotherapy for cervical cancer.
Keywords:cervical cancer  neoadjuvant chemotherapy  AKT  P-AKT  lymphatic microvessel density
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号